secwatch.observer — SEC 8-K summary
======================================

Issuer:     HAEMONETICS CORP (HAE)
CIK:        0000313143
Form:       8-K
Filed at:   2024-02-08T23:59:59+00:00
Accession:  0000313143-24-000006
Event type: earnings
Sentiment:  neutral
Materiality: 0.40
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Haemonetics reports Q3 FY2024 results; specific figures not available in provided text
--------------------------------------------------------------------------------

- Filed an 8-K on Feb 8, 2024, announcing Q3 and nine-month results for period ended Dec 30, 2023.
- Press release issued as Exhibit 99.1 but full financial details are not included in the provided filing text.
- Investor should refer to the complete press release for specific revenue, EPS, and segment data.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/313143/000031314324000006/0000313143-24-000006-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/313143/000031314324000006/hae-20240208.htm
  HTML page:      https://secwatch.observer/filing/0000313143-24-000006

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer